ÁNGEL
GIL HERNÁNDEZ
Investigador desde 2024
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (18)
2023
-
Longitudinal associations between cardiovascular biomarkers and metabolic syndrome during puberty: the PUBMEP study
European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 419-429
-
Serum levels of the novel adipokine isthmin-1 are associated with obesity in pubertal boys
World Journal of Pediatrics, Vol. 19, Núm. 9, pp. 864-872
2022
-
Impact of Physical Activity Intensity Levels on the Cardiometabolic Risk Status of Children: The Genobox Study
International journal of sport nutrition and exercise metabolism, Vol. 32, Núm. 2, pp. 102-110
-
Progression of metabolic syndrome and associated cardiometabolic risk factors from prepuberty to puberty in children: The PUBMEP study
Frontiers in Endocrinology, Vol. 13
2021
-
Association of diet, physical activity guidelines and cardiometabolic risk markers in children
Nutrients, Vol. 13, Núm. 9
-
Evaluation of Sedentary Behavior and Physical Activity Levels Using Different Accelerometry Protocols in Children from the GENOBOX Study
Sports Medicine - Open, Vol. 7, Núm. 1
-
Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial
Biomedicine and Pharmacotherapy, Vol. 134
-
Relationship between physical activity, oxidative stress, and total plasma antioxidant capacity in spanish children from the genobox study
Antioxidants, Vol. 10, Núm. 2, pp. 1-14
2020
-
Antioxidants and oxidative stress in children: Influence of puberty and metabolically unhealthy status
Antioxidants, Vol. 9, Núm. 7, pp. 1-19
-
Dietary Patterns and Their Association with Body Composition and Cardiometabolic Markers in Children and Adolescents: Genobox Cohort
Nutrients, Vol. 12, Núm. 11
-
Evaluation of the predictive ability, environmental regulation and pharmacogenetics utility of a bmi-predisposing genetic risk score during childhood and puberty
Journal of Clinical Medicine, Vol. 9, Núm. 6
2019
-
ANGPTL-4 is associated with obesity and lipid profile in children and adolescents
Nutrients, Vol. 11, Núm. 6
-
Common variants in 22 genes regulate response to metformin intervention in children with obesity: A pharmacogenetic study of a randomized controlled trial
Journal of Clinical Medicine, Vol. 8, Núm. 9
2018
-
Cardiovascular risk biomarkers and metabolically unhealthy status in prepubertal children: Comparison of definitions
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 28, Núm. 5, pp. 524-530
2017
-
Metformin for obesity in prepubertal and pubertal children: A randomized controlled trial
Pediatrics, Vol. 140, Núm. 1
2015
-
A continuous metabolic syndrome score is associated with specific biomarkers of inflammation and CVD risk in prepubertal children
Annals of Nutrition and Metabolism, Vol. 66, Núm. 2-3, pp. 72-79
2014
-
Waist-to-height ratio, inflammation and CVD risk in obese children
Public Health Nutrition, Vol. 17, Núm. 10, pp. 2378-2385
2012
-
Myeloperoxidase is an early biomarker of inflammation and cardiovascular risk in prepubertal obese children
Diabetes Care, Vol. 35, Núm. 11, pp. 2373-2376